ANDA 80081, held by Impax Labs. Sulfadiazine.
As of Nov 16, 2026, ANDA 80081 (Sulfadiazine), held by Impax Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Sulfadiazine500MG ยท tablet;oral | Sulfadiazine | DiscontinuedReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters